Table 4.
Analysis of change from baseline at midpoint and study end.
| Outcome | Month 6 | Month 12 | ||||
|
|
Control, ORa (95% CI) | Intervention, OR (95% CI) | P value | Control, OR (95% CI) | Intervention, OR (95% CI) | P value |
| Patient Activation Measure score | 4.81 (2.21 to 7.42) | 1.57 (−1.34 to 4.48) | .10 | 7.49 (4.44 to 10.55) | 1.77 (−1.02 to 4.57) | .007 |
| Summary of Diabetes Self-Care Activities score | 7.52 (5.43 to 9.61) | 7.52 (5.30 to 9.73) | >.99 | 6.97 (4.40 to 9.55) | 7.52 (5.06 to 9.97) | .77 |
| Glycated hemoglobin | −0.36 (−0.57 to −0.14) | −0.18 (−0.36 to 0.01) | .21 | −0.53 (−0.78 to −0.29) | −0.11 (−0.28 to 0.07) | .006 |
| BMI (kg/m2) | −0.31 (−0.62 to 0.00) | −0.28 (−0.53 to −0.02) | .86 | −0.45 (−0.82 to −0.07) | −0.36 (−0.62 to −0.10) | .72 |
| Waist (inches) | −0.57 (−0.96 to −0.19) | −0.76 (−1.09 to −0.44) | .46 | −1.46 (−1.95 to −0.98) | −1.49 (−1.90 to −1.07) | .95 |
| Diastolic blood pressure (mm Hg) | −1.83 (−3.81 to 0.15) | −0.58 (−2.30 to 1.14) | .35 | −2.18 (−3.98 to −0.38) | −1.72 (−3.22 to −0.22) | .70 |
| Systolic blood pressure (mm Hg) | −2.90 (−6.31 to 0.52) | 0.57 (−3.13 to 4.26) | .18 | −2.88 (−6.63 to 0.87) | −1.63 (−4.99 to 1.74) | .63 |
| High-density lipoproteincholesterol (mg/dL) | 1.22 (−0.12 to 2.57) | 1.59 (−0.39 to 3.58) | .76 | −1.39 (−2.82 to 0.03) | −0.26 (−2.26 to 1.74) | .37 |
| Low-density lipoprotein cholesterol (mg/dL) | −5.78 (−11.22 to −0.33) | 0.12 (−5.69 to 5.93) | .15 | −7.14 (−13.43 to −0.85) | 4.38 (−2.16 to 10.91) | .01 |
aOR: odds ratio.